Biotechnology News and Research

RSS

ICON announces results of new survey that examines key challenge of R&D efficiency

ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the results from a new survey of pharmaceutical executives and professionals by ICON and Pharma Intelligence, which examines the key challenge of declining research and development efficiency

9 May 2018

Experts discuss how medicinal cannabis can impact opioid crisis

A multidisciplinary panel of experts discussed how medicinal cannabis can impact the opioid crisis, though clinical research to quantify this is difficult given strict federal laws

9 May 2018

Scientists unlock secrets of extraordinary jumping capability of predatory spiders

Scientists have unlocked the secrets of how some predatory spiders catch their prey whilst hunting by successfully training one to jump different distances and heights for the first time.

8 May 2018

Researchers harness the precision of CRISPR to knock out single genes in yeast

Researchers have used CRISPR-Cas9 to develop a technology that can precisely target any gene in the yeast species Saccharomyces cerevisiae.

8 May 2018

Simplified Mammalian Cell Harvesting without Centrifuging

Centrifuging adds time and can potentially damage the cell sample, Michael Grauf discusses how cell clarification and sterile filtration can be achieved in one step.

From Sartorius 8 May 2018

Study shows advantages of using decellularized muscle to promote tissue regeneration

A new comparative study showed the advantages of using donor decellularized muscle to promote functional tissue regeneration at the site of bulk skeletal muscle loss due to trauma or surgery.

4 May 2018

Researchers uncover novel approach for treating neuropathic pain

Neuropathic pain is the chronic, pathological pain that continues even when the cause of pain is removed. Causes include damage to nerve cells and medicines used to treat cancer.

4 May 2018

Charles River Laboratories Expands Services for Early Discovery Screening

Charles River Laboratories International, Inc. recently announced the expansion of its service capabilities in early discovery screening.

4 May 2018

Sylentis presents clinical study results of new treatment for dry eye syndrome

Sylentis, Pharmaceutical Company belonging to the PharmaMar Group, has presented results from the clinical studies carried out with tivanisiran for the treatment of dry eye syndrome and that has enabled the start-up of the Phase III "Helix" clinical trial.

3 May 2018

‘Splash Away Cancer!’ swimming fundraiser slated for May 19

The 'Splash Away Cancer!' event will take place Saturday, May 19. The swimming fundraiser supports cancer research and patient care programs at The University of New Mexico Comprehensive Cancer Center. The event is sponsored by the Lobo Aquatic Club, UNM Recreational Services and New Mexico Masters Swimming.

2 May 2018

Study: HCV-exposed infants not adequately screened, despite increased prevalence

Due to the opioid epidemic, hepatitis C virus is increasing among pregnant women, resulting in a greater risk of perinatal transmission and HCV infection among children.

2 May 2018

Researchers evaluate predictive value of stress testing and cardiac biomarkers in older women

Mayo Clinic researchers, reporting results of the SMART study, have shown that abnormal results on a stress electrocardiogram are an independent predictor of cardiovascular events such as heart attack, heart failure, hospitalization for chest pain, and death in perimenopausal or menopausal women.

2 May 2018

Gene therapy offers potential cure for patients with lipoprotein lipase deficiency

During the first 18 months after treatment with ali-pogene tiparvovec, a gene therapy recently approved in Europe to treat lipoprotein lipase deficiency (LPLD), the first patient to receive the treatment had no abdominal pain or episodes of pancreatitis, following a history of 37 pancreatitis attacks.

2 May 2018

Utah life sciences companies among 10 innovative companies to win the 16th annual Utah Innovation Awards

Utah life sciences companies, and BioUtah members, ProLung, Inc., and Rosivo Inc., were among ten innovative companies announced as winners in the 16th annual Utah Innovation Awards, presented by Stoel Rives, LLP, and the Utah Technology Council.

28 Apr 2018

BIO announces programming information for gene editing and synthetic biology at 2018 World Congress

The Biotechnology Innovation Organization (BIO) today announced programming information for gene editing and synthetic biology at the 2018 World Congress on Industrial Biotechnology.

28 Apr 2018

BIO issues statement regarding Opioid Addiction Action Plan Act

BIO President and CEO Jim Greenwood issued the following statement regarding the Opioid Addiction Action Plan Act, introduced yesterday in the Senate by Senators Heller (R-NV), Isakson (R-GA), and Menendez (D-NJ).

28 Apr 2018

Insilico’s CEO to deliver presentation on “Artificial Intelligence for Aging Research”

Insilico Medicine, a Baltimore-based company specializing in the application of next-generation artificial intelligence for drug discovery, biomarker development and aging research, announces the presentation of its CEO, Alex Zhavoronkov, at the Pioneers 18 Conference, May 25, 2018, Vienna, Austria.

28 Apr 2018

Accelerator Life Science Partners launches new company to develop novel therapy for seizure disorders

Accelerator Life Science Partners (Accelerator), a leading life science investment and management firm, today announced that it has launched Proniras Corporation, a company developing tezampanel for the treatment of a variety of seizure disorders.

27 Apr 2018

Scientists improve growth of 3d brain models to better understand autism, dementia, schizophrenia

Salk Institute scientists recently have developed a method to make micro brain structures in the lab. These microbrain tissues are designated to be used in research for treatment of neurological diseases such as Alzheimer’s disease or Parkinson’s disease.

26 Apr 2018

$2 million funding boosts progress of UAB biomedical startup

A $2 million investment is the latest step forward for the biomedical startup CNine Biosolutions LLC, which is headed by former University of Alabama at Birmingham postdoctoral fellow Theresa Schein, Ph.D., and retired UAB microbiology professor Scott Barnum, Ph.D. This funding comes from a Denver angel investor group.

20 Apr 2018

Biotechnology News and Research

ICON announces results of new survey that examines key challenge of R&D efficiency

Experts discuss how medicinal cannabis can impact opioid crisis

Scientists unlock secrets of extraordinary jumping capability of predatory spiders

Researchers harness the precision of CRISPR to knock out single genes in yeast

Simplified Mammalian Cell Harvesting without Centrifuging

Study shows advantages of using decellularized muscle to promote tissue regeneration

Researchers uncover novel approach for treating neuropathic pain

Charles River Laboratories Expands Services for Early Discovery Screening

Sylentis presents clinical study results of new treatment for dry eye syndrome

‘Splash Away Cancer!’ swimming fundraiser slated for May 19

Study: HCV-exposed infants not adequately screened, despite increased prevalence

Researchers evaluate predictive value of stress testing and cardiac biomarkers in older women

Gene therapy offers potential cure for patients with lipoprotein lipase deficiency

Utah life sciences companies among 10 innovative companies to win the 16th annual Utah Innovation Awards

BIO announces programming information for gene editing and synthetic biology at 2018 World Congress

BIO issues statement regarding Opioid Addiction Action Plan Act

Insilico’s CEO to deliver presentation on “Artificial Intelligence for Aging Research”

Accelerator Life Science Partners launches new company to develop novel therapy for seizure disorders

Scientists improve growth of 3d brain models to better understand autism, dementia, schizophrenia

$2 million funding boosts progress of UAB biomedical startup

Event guide: 3rd IMPACCT Real World Evidence Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News